Medicine for treating cerebrovascular sequelae

A technology for cerebrovascular disease and sequelae, applied in the field of medicine, can solve the problems of long treatment cycle, high cost and poor treatment effect, and achieve the effect of reasonable composition, effective treatment and obvious effect.

Inactive Publication Date: 2015-07-22
蒋晓云
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, but long-term infusion, taking antihypertensive and blood lipid-lowering drugs can only lower blood pressure and relieve heart function, but cannot remove thrombus, dilate blood vessels, nourish qi and blood, Good circulatory effects such as sperm production and fluid production, the treatment effect is not good, the treatment cycle is long, and the cost is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0009] The preparation of embodiment decoction of the present invention

[0010] Take 90 grams of sheep seven lotus, 80 grams of cycad fern, 80 grams of crossing dragon seed, 70 grams of Duganshan, 70 grams of Lingxiang, 60 grams of chicken tendon ginseng, 60 grams of Qingtiankui, 50 grams of medicinal inverted pot, Add 50 grams of bell beans, 30 grams of yellow water branch, 20 grams of sugar root and 10 grams of licorice, add 11000 ml of water, heat under reflux for 6 hours, filter, and cool the filtrate to room temperature.

experiment example

[0012] Diagnostic criteria

[0013] The diagnosis standard of traditional Chinese medicine adopts "Stroke Disease Diagnosis and Curative Effect Evaluation Standard" (Ren Zhanli, Wang Shundao. Stroke Disease Diagnosis and Curative Effect Evaluation Standard. Journal of Beijing University of Traditional Chinese Medicine, 1996,19(1); 55-56.), Western medicine diagnosis standard reference "Key Points of Diagnosis of Various Cerebrovascular Diseases" (Wang Xinde. Key Points of Diagnosis of Various Cerebrovascular Diseases. Chinese Journal of Neurology, 1996, 29(6); 379-381.).

[0014] standard constrain

[0015] ① 24 hours after the onset of cerebral thrombosis, and 48 hours after the onset of cerebral hemorrhage, it was confirmed by head CT as sequelae of cerebrovascular disease. The infarction site is in the basal ganglia and temporal lobe, and the infarction size is ≤18cm 2 . The bleeding site is in the basal ganglia, subarachnoid space, brain lobe, and cerebellum, and the am...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating cerebrovascular sequelae. The medicine is prepared from the following medicinal raw materials in parts by weight: 90 parts of polypodium ellipticum thunb, 80 parts of brainea insignis, 80 parts of bauhinia seeds, 70 parts of maesa japonica, 70 parts of lysimachia foenum-graecum, 60 parts of damnacanthus macrophyllus, 60 parts of nervilia fordii, 50 parts of cynoglossum officinale, 50 parts of crotalaria albida, 30 parts of tiarella polyphylla, 20 parts of capitellate hedyotis herb, and 10 parts of liquorice. The medicine for treating cerebrovascular sequelae disclosed by the invention is reasonable in composition and obvious in effect and is capable of effectively treating cerebrovascular sequelae.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicine for treating sequelae of cerebrovascular diseases. Background technique [0002] Cerebrovascular disease refers to a group of diseases with cerebral hemorrhagic or ischemic injury symptoms as the main clinical manifestation caused by cerebral blood vessel rupture and bleeding or thrombosis, commonly known as "stroke". The incidence rate is higher in men than in women. After the disease has been treated in time by the hospital to achieve clinical treatment, there will still be sequelae such as mild paralysis or hemiplegia, limb numbness, sensory disturbance, movement disturbance, slurred pronunciation, ataxia, dizziness, tinnitus, and diplopia. At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, but long-term infusion, taking antihypertensive and blood lipid drugs can only lower blood pressure and relieve heart function, but ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P9/10A61P25/00A61P25/14A61P1/08A61P27/16A61P27/02
Inventor 蒋晓云
Owner 蒋晓云
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap